Literature DB >> 17475803

Conditional NF-L transgene expression in mice for in vivo analysis of turnover and transport rate of neurofilaments.

Stéphanie Millecamps1, Geneviève Gowing, Olga Corti, Jacques Mallet, Jean-Pierre Julien.   

Abstract

We generated mice with doxycycline control of a human neurofilament light (NF-L) transgene in the context of the absence (tTA;hNF-L;NF-L(-/-)) or presence (tTA;hNF-L;NF-L(+/-)) of endogenous mouse NF-L proteins. Doxycycline treatment caused the rapid disappearance of human NF-L (hNF-L) mRNA in tTA;hNF-L mice, but the hNF-L proteins remained with a half-life of 3 weeks in the brain. In the sciatic nerve, the disappearance of hNF-L proteins after doxycycline treatment occurred in synchrony along the sciatic nerve, suggesting a proteolysis of NF proteins along the entire axon. The presence of permanent NF network in tTA;hNF-L;NF-L(+/-) mice further stabilized and extended longevity of hNF-L proteins by several months. Surprisingly, after cessation of doxycycline treatment, there was no evidence of leading front of newly synthesized hNF-L proteins migrating into sciatic nerve axons devoid of NF structures. The hNF-L proteins detected at weekly intervals reappeared and accumulated in synchrony at similar rate along nerve segments, a phenomenon consistent with a fast hNF-L transport into axons. We estimated the hNF-L transport rate to be of approximately 10 mm/d in axons devoid of NF structures based on the use of an adenovirus encoding tet-responsive transcriptional activator to transactivate the hNF-L transgene in hypoglossal motor neurons. These results provide in vivo evidence that the stationary NF network in axons is a key determinant of half-life and transport rate of NF proteins.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17475803      PMCID: PMC6672085          DOI: 10.1523/JNEUROSCI.5299-06.2007

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  27 in total

1.  Drug screening to identify suppressors of GFAP expression.

Authors:  Woosung Cho; Michael Brenner; Noel Peters; Albee Messing
Journal:  Hum Mol Genet       Date:  2010-06-10       Impact factor: 6.150

Review 2.  SILK studies - capturing the turnover of proteins linked to neurodegenerative diseases.

Authors:  Ross W Paterson; Audrey Gabelle; Brendan P Lucey; Nicolas R Barthélemy; Claire A Leckey; Christophe Hirtz; Sylvain Lehmann; Chihiro Sato; Bruce W Patterson; Tim West; Kevin Yarasheski; Jonathan D Rohrer; Norelle C Wildburger; Jonathan M Schott; Celeste M Karch; Selina Wray; Timothy M Miller; Donald L Elbert; Henrik Zetterberg; Nick C Fox; Randall J Bateman
Journal:  Nat Rev Neurol       Date:  2019-06-20       Impact factor: 42.937

Review 3.  Review of the multiple aspects of neurofilament functions, and their possible contribution to neurodegeneration.

Authors:  Rodolphe Perrot; Raphael Berges; Arnaud Bocquet; Joel Eyer
Journal:  Mol Neurobiol       Date:  2008-07-23       Impact factor: 5.590

4.  "Panta rhei": Perpetual cycling of the keratin cytoskeleton.

Authors:  Rudolf E Leube; Marcin Moch; Anne Kölsch; Reinhard Windoffer
Journal:  Bioarchitecture       Date:  2011-01

5.  A transgenic mouse model of neuroepithelial cell specific inducible overexpression of dopamine D1-receptor.

Authors:  K Fujimoto; K Araki; D M McCarthy; J R Sims; J Q Ren; X Zhang; P G Bhide
Journal:  Neuroscience       Date:  2010-07-29       Impact factor: 3.590

Review 6.  Neurofilaments at a glance.

Authors:  Aidong Yuan; Mala V Rao; Ralph A Nixon
Journal:  J Cell Sci       Date:  2012-07-15       Impact factor: 5.285

Review 7.  A critical reevaluation of the stationary axonal cytoskeleton hypothesis.

Authors:  Anthony Brown; Peter Jung
Journal:  Cytoskeleton (Hoboken)       Date:  2012-10-29

8.  Myosin Va increases the efficiency of neurofilament transport by decreasing the duration of long-term pauses.

Authors:  Nael H Alami; Peter Jung; Anthony Brown
Journal:  J Neurosci       Date:  2009-05-20       Impact factor: 6.167

9.  Modest loss of peripheral axons, muscle atrophy and formation of brain inclusions in mice with targeted deletion of gigaxonin exon 1.

Authors:  Florence Dequen; Pascale Bomont; Geneviève Gowing; Don W Cleveland; Jean-Pierre Julien
Journal:  J Neurochem       Date:  2008-07-31       Impact factor: 5.372

Review 10.  Role of animal studies in the design of clinical trials.

Authors:  Edward D Hall; Richard J Traystman
Journal:  Front Neurol Neurosci       Date:  2009-03-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.